Pfizer looks for federal approval for COVID-19 antiviral pill


Pfizer recently announced its COVID-19 antiviral pill regimen was so effective at preventing death and hospitalization in clinical trials that it was ending the study early and applying for FDA approval.

The drugs have been described as a potential game-changer in the pandemic.

CGTN’s Karina Huber reports.